Skip to content
Screener

Maze Therapeutics MAZE Invested capital

Discontinued — last reported Q2 '26

Invested capital at other companies

Oneok logo
OneokOKE
8.6%-0.2pp
Rithm Capital logo
Rithm CapitalRITM
3.2%0.0pp
Citigroup logo
CitigroupC
32.6%+2.0pp
Morgan Stanley logo
Morgan StanleyMS
16.9%+0.4pp
Wells Fargo & Company logo
Wells Fargo & CompanyWFC
20.5%-0.7pp
American Express logo
American ExpressAXP
49.1%-10.0pp

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$48.0M-31.7%
Net income-$44.7M-32.8%
EPS (diluted)-$0.76+1.3%

Balance sheet

See full
Cash & equivalents$202.6M-23.4%
Total debt$60.4M+142%
Total equity$453.1M+72.8%
Total assets$531.6M+75.2%

Cash flow

See full
Operating cash flow-$15.1M+49.9%
CapEx$107.0K-72.8%
Free cash flow-$15.2M+50.2%

Valuation

See full
Market cap$1.51B+156%
Enterprise value$1.37B+290%

Returns & leverage

See full
Return on equity-37.3%
Debt / equity0.1×0.0×
Current ratio18.3×+4.7×

Where this comes from

Calculated from Maze Therapeutics’s reported figures.

The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:48 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344903

FAQ

What is Maze Therapeutics's invested capital?
Maze Therapeutics (MAZE) reported invested capital of $310.9M in Q2 2026.
How has Maze Therapeutics's invested capital changed year-over-year?
Maze Therapeutics's invested capital increased by 1269.3% year-over-year, from $22.71M to $310.9M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).

Ask your AI about Maze Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude